Literature DB >> 18931971

The pathogenic role of interleukin-27 in autoimmune diabetes.

R Wang1, G Han, J Wang, G Chen, R Xu, L Wang, X Li, B Shen, Y Li.   

Abstract

Interleukin (IL)-27 is an IL-12-related cytokine that can promote both anti- and pro-inflammatory immune responses. This study investigated the potential role of IL-27 in autoimmune diabetes. We detected a high level of IL-27 in diabetic NOD mice. In addition, blockade of IL-27 significantly delayed the onset of diabetic splenocyte-transferred diabetes, while IL-27-treated diabetic splenocytes promoted the onset of the disease, compared with untreated controls. Furthermore, IL-27 up-regulated pro-inflammatory cytokines IFN-gamma and IL-17 and down-regulated anti-inflammatory cytokines IL-4, TGF-beta, and IL-10 secreted by diabetic splenocytes. These results demonstrate a pathogenic role of IL-27 in T cell-mediated autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931971     DOI: 10.1007/s00018-008-8540-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  18 in total

1.  Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27.

Authors:  George D Kalliolias; Rachael A Gordon; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

2.  The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.

Authors:  Preeti Chhabra; Joel Linden; Peter Lobo; Mark Douglas Okusa; Kenneth Lewis Brayman
Journal:  Curr Diabetes Rev       Date:  2012-11

Review 3.  Cytokines in autoimmunity: role in induction, regulation, and treatment.

Authors:  Kamal D Moudgil; Divaker Choubey
Journal:  J Interferon Cytokine Res       Date:  2011-09-23       Impact factor: 2.607

4.  Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis.

Authors:  Rajesh Rajaiah; Muraly Puttabyatappa; Swamy K Polumuri; Kamal D Moudgil
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 5.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

6.  IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice.

Authors:  Hirokazu Fujimoto; Tetsuaki Hirase; Yoshiyuki Miyazaki; Hiromitsu Hara; Noriko Ide-Iwata; Ai Nishimoto-Hazuku; Christiaan J M Saris; Hiroki Yoshida; Koichi Node
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

Review 7.  Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

Authors:  Anabelle Visperas; Dario A A Vignali
Journal:  J Immunol       Date:  2016-11-15       Impact factor: 5.422

8.  Temporal response characterization across individual multiomics profiles of prediabetic and diabetic subjects.

Authors:  Minzhang Zheng; Carlo Piermarocchi; George I Mias
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

Review 9.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

10.  New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27.

Authors:  Fatemeh Zamani; Shohreh Almasi; Tohid Kazemi; Rana Jahanban Esfahlan; Mohammad Reza Aliparasti
Journal:  Adv Pharm Bull       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.